Effects of pulmonary vascular obstruction on right ventricular afterload.
We compared the effects of three forms of vascular obstruction: positive end-expiratory pressure (PEEP), ensnarement of the left main pulmonary artery (SN), and pulmonary thromboembolism (EMB) on right ventricular afterload. We measured right ventricular and pulmonary arterial pressures and flow in open-chested dogs under anesthesia (n = 8). Pulmonary artery input impedance (Zin) was calculated by Fourier analysis of the pressure and flow waves. Characteristic impedance (Zc) and pulmonary arterial compliance (Ca) were estimated from Zin with a lumped parameter model. Although PEEP, SN, and EMB all increased mean pulmonary arterial pressure, PEEP, had negligible effect on Zc and Ca, whereas SN increased Zc but decreased Ca (+24% and -49%, respectively), and EMB decreased both Zc and Ca (-33% and -39%, respectively). These changes of Zc affect wave reflection and alter the energy transmission ratio, which is the ratio of hydraulic power output in the measured and forward waves (Wm/Wf). Under control conditions, Wm/Wf was 62% and was not affected significantly by SN (59%) or by PEEP (46%), but it fell significantly to 30% after EMB. Simulation of these experiments in a mathematical model suggested that the increase of Zc with SN was due to an active neurohumoral effect; all other responses were consistent with passive mechanical effects. In additional experiments, we tested the effects of meclofenamate (n = 6) and ketanserin (n = 6) and of atropine and vagotomy (n = 5) on the response to SN and EMB. The serotonin antagonist, ketanserin, blunted the increase of Zc to SN, but none of the interventions significantly affected the response of Zc or Ca to EMB.(ABSTRACT TRUNCATED AT 250 WORDS)
Fitzpatrick
J M
JM
Department of Medicine, State University of New York, Buffalo.
Grant
B J
BJ
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001696:Biomechanical Phenomena; D003187:Compliance; D003250:Constriction; D004285:Dogs; D007650:Ketanserin / Q000494:pharmacology; D008469:Meclofenamic Acid / Q000494:pharmacology; D008955:Models, Cardiovascular; D011175:Positive-Pressure Respiration; D011651:Pulmonary Artery / Q000502:physiology; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology*; D011655:Pulmonary Embolism / Q000503:physiopathology*; D011673:Pulsatile Flow; D014628:Vagotomy; D014655:Vascular Resistance; D016276:Ventricular Function
D008469:Meclofenamic Acid; D001285:Atropine; D007650:Ketanserin